Design and validation of an Index to predict the development of Hypertensive Cardiopathy
Article Sidebar
Main Article Content
Abstract
Introduction: The high morbidity and mortality by hypertensive cardiopathy demand the construction and validation of tools to stratify the risk of developing this condition.
Objective: To design and validate an index, based on risk factors, that permits to predict the development of hypertensive cardiopathy in patients with a diagnosis of essential arterial hypertension.
Methods: A prospective cohort study was done in hypertensive patients assisted at the specialized arterial hypertension physicians’ office of the “Carlos Manuel de Céspedes” Specialty Policlinic attached to the General University Hospital, Bayamo Municipality, Granma Province, Cuba from January 1st, 2010 to December 31, 2016. Internal and external validity and the internal consistency of the index were determined.
Results: The index sensitivity was of 97, 20 (IC: 93, 93-94.09) and specificity of 65, 38 (IC: 76, 25-76, 20). Both the index discriminative capacity (area under the ROC curve= 0,944; interval of confidence: 0.932-0.956; p<0.0005) and calibration (p=0.751) were adequate.
Conclusions: The present study proposes an index to predict the risk of developing hypertensive cardiopathy, with adequate discriminative capacity and calibration (external validity). The index can be used as a tool of clinical and epidemiological surveillance since it permits to identify subjects with greater probability of developing the condition and to stratify the risk.
Article Details
Copyright (c) 2018 Álvarez-Aliaga A, et al.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Journal of Cardiology and Cardiovascular Medicine is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | 
Open Access by Journal of Cardiology and Cardiovascular Medicine is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
| Permission to read and download | ✓ |
| Permission to display in a repository | ✓ |
| Permission to translate | ✓ |
| Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 report. 2003; 289: 2560-2572. Ref.: https://goo.gl/s9MtBw
República de Cuba. Anuario Estadístico de Salud; 2016. [citado 10 abril 2017]. Disponible en.
Tientcheu D, Ayers C, Das SR, McGuire DK, de Lemos JA, et al. Target organ complications and cardiovascular events associated with masked hypertension and white-coat hypertension. Analysis from the Dallas heart study. Am Coll Cardiol. 2015; 66: 2159-2169. Ref.: https://goo.gl/B4sMN3
Díez J, Frohlich E D. A translational approach to hypertensive heart disease. Hypertension. 2010; 55: 1-8. Ref.: https://goo.gl/xNGLyg
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, et al. Guía de práctica clínica de la ESH/ESC 2013 para el manejo de la hipertensión arterial. Rev Esp Cardiol. 2013; 66: 880.
Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burniere M, et al. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. J Hypertens. 2009; 27: 2121-2158. Ref.: https://goo.gl/HBrVk9
Maione A, Annemans L, Strippoli G. Proteinuria and clinical outcomes in hypertensive patients. Am J Hypertens. 2009; 22: 1137-1147. Ref.: https://goo.gl/w2pMxY
Angeli F, Ambrosio G. Mecanismos de la hipertrofia ventricular izquierda en la hipertensión: más que solo la presión arterial. Rev Argent Cardiol. 2015; 83: 6-7. Ref.: https://goo.gl/1BKVsC
Harbaoui B, Courand PY, Defforges A, Khettab F, Milon H, et al. Cumulative effects of several target organ damages in risk assessment in hypertension. Am J Hypertens. 2016; 29: 234-244. Ref.: https://goo.gl/MFLhNw
Wang SX, Xue H, Zou YB, Sun K, Fu CY, et al. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese. Chin Med J. 2012; 125: 21-26. Ref.: https://goo.gl/SesKhT
Sharman J E. New insights into cardiovascular risk from the exercise central waveform. Artery Res. 2009; 2: 132-137. Ref.: https://goo.gl/Zd9a6A
García Iglesias A, Lozano Alonso J E, Álamo Sanz R, Vega Alonso T. Factores asociado al control de la presión arterial en la cohorte del estudio del riesgo de enfermedad cardiovascular en Castilla y León (RECCyL). Hipertens Riesgo Vasc. 2015; 32: 48-55. Ref.: https://goo.gl/AAKq4U
Dévereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977; 55: 613-618. Ref.: https://goo.gl/VwxWXY
Khouri MG, Peshock RM, Ayers CR, de Lemos JA, Drazner MH. A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: The Dallas Heart Study. Circ Cardiovasc Imaging. 2010; 3: 164-171. Ref.: https://goo.gl/8Fnptm
Fuster V, Rydén L E, Cannom D S, Crijns H J, Curtis A B, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2011; 123: 104-123. Ref.: https://goo.gl/uYTEgW
Pérez Caballero MD, Dueñas Herrera A, Alfonso Guerra JP, Vázquez Vigoa A, Navarro Despaigne D, et al. Hipertensión arterial. Guía para la prevención, diagnóstico y tratamiento. Comisión Nacional Técnica Asesora del Programa de Hipertensión Arterial. La Habana: Editorial Ciencias Médicas. 2008. Ref.: https://goo.gl/d9zaUu
Whelton S, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2002; 136: 493-503. Ref.: https://goo.gl/FsyiuG
Cabrera de León A, Rodríguez-Pérez C, Rodríguez-Benjumeda M, Anía-Lafuente B, Brito-Díaz B, et al. Sedentarismo: tiempo de ocio activo frente a porcentaje del gasto energético. Rev Esp Cardiol. 2007; 60: 244-250. Ref.: https://goo.gl/9V1PG6
Zhao W, Hasegawa K, Chen J. Part A. Recent advances in dietary assessment tools. The use of food-frequency questionnaires for various purposes in China. Public Health Nutrition. 2002; 5, 829-833. Ref.: https://goo.gl/Romh5u
Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010; 303: 2043-2050. Ref.: https://goo.gl/JHFMTu
Álvarez Aliaga A, González Aguilera JC, Maceo Gómez LR. Factores asociados al desarrollo de la cardiopatía hipertensiva: un estudio de cohorte, en Bayamo, Cuba. Medwave. 2016; 16. Ref.: https://goo.gl/csGC8P
Moriyama IM. Problems in the measurement of health status. En: Sheldon EB, Moore W. eds. Indicators of social change: concepts and measurements. New York: Rusell Sage fundation. 1968: 573-599.
D'Agostino RB, Grundy S, Sullivan LM, Wilson P, for the CHD Risk Prediction Group. Validation of the Framingham Coronary Heart Disease Prediction Scores. Results of a multiple ethnic groups investigation. JAMA. 2001; 286:180-187. Ref.: https://goo.gl/UBzXFm
Álvarez Aliaga A, González Aguilera JC, Quesada Vázquez AJ, Frómeta Guerra A, Cisneros Sánchez L, Maceo Gómez LR. Índice predictivo para la cardiopatía hipertensiva. Rev Cubana de Med. 2010; 49: 311-329. Ref.: https://goo.gl/2pBkEe
Drazner M H. The Progression of Hypertensive Heart Disease. Circulation. 2011; 123: 327-334. Ref.: https://goo.gl/chYmgm
Cuspidi C, Giudici V, Negri F, Meani S, Sala C, et al. Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height(2.7). J Hypertens. 2009; 27: 2465-2471. Ref.: https://goo.gl/Jvobsg
Gu Q, Dillon CF, Burt VL, Gillum RF. Association of hypertension treatment and control with all-cause and cardiovascular disease mortality among US adults with hypertension. Am J Hypertens. 2010; 23: 38-45. Ref.: https://goo.gl/k3x92g
Peralta CA, Katz R, Newman AB, Psaty BM, Odden MC. Systolic and diastolic blood pressure, incident cardiovascular events, and death in elderly persons: the role of functional limitation in the Cardiovascular Health Study. Hypertension.2014; 64: 472-480. https://goo.gl/d2GVgz
Álvarez Aliaga A, González Aguilera JC. Algunos factores de riesgo de la cardiopatía hipertensiva. Rev Cubana de Med. 2009; 48: 139-151. Ref.: https://goo.gl/vSJHBL
De la Noval García R, Armas Rojas NB, de la Noval González I, Fernández González Y, Pupo Rodríguez HB, et al. Estimación del riesgo cardiovascular global en una población del área de salud Mártires del Corynthia. Ciudad Habana, Cuba. Rev Cubana Cardiol Cir Cardiovasc. 2011; 17: 62-68. Ref.: https://goo.gl/77vWvG
Armas Rojas NB, De la Noval García R, Dueñas Herrera A, Castillo Núñez JC, Suárez Medina R, et al. Estimación del riesgo cardiovascular mediante tablas de la Organización Mundial de la Salud. Área de salud “Héroes del Moncada”. 2011. Rev Cubana Cardiol Cir Cardiovasc. 2014; 20. Ref.: https://goo.gl/x1U0K2
D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, et al. General cardiovascular risk profile for use in primary care the Framingham heart study. Circulation. 2008; 117: 743-753. Ref.: https://goo.gl/XgFgAh
Ang DSC, Fahey TP, Wright GA, Struthers AD. Development and validation of a clinical score to identify echocardiographic left ventricular hypertrophy in patients with cardiovascular disease. Am J Hypertens.2008; 21: 1011-1017. Ref.: https://goo.gl/8VWSLa
Creemers EE, Pinto YM. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res. 2011; 89: 265-272. Ref.: https://goo.gl/fJ85zY
Drazner MH. The Progression of Hypertensive Heart Disease. Circulation. 2011; 123: 327-334. Ref.: https://goo.gl/chYmgm
Feinstein AR, Cicchetti DV. High agreement but low kappa: I. The problem of two paradoxes. J Clin Epidemiol. 1990; 43: 543-549. Ref.: https://goo.gl/8NisKG
Streiner DL, Norman GR. Health measurement scales. A practical guide to their development and use. Oxford: Oxford University Press; 1989: 144-161.
García Cadena CH. La medición en las ciencias sociales y la psicología, en estadística con SPSS y metodología de la investigación de René Landeros Hernández y Mónica T González Ramírez. México, Trillas (comp). 2006. Ref.: https://goo.gl/RY1Qad